speb/financial-data huggingface dataset:
Stock screener scorecard for EPL.V (quarterly, report date 2026-03-31)
Altman Z-score: 2.1585592702156613 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.0463670854004057%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.7788086442361632%
Free cash flow margin: 5.835754492953359%
Revenue growth: 96.16592623899399%
Rule of 40 score: 102.00168073194735
Market cap: 20736402 (Nano Cap (< $50M))
P/E ratio: 7.194244604316547
Debt to equity: 0
Free cash flow (dilution adjusted): 287330.2158273381
Operating income: -363630.21582733816
Net income: 73565.46762589928
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ETL.V (quarterly, report date 2026-03-31)
Altman Z-score: 4.888709893014301 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -17.759646647444946%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.204426964236715%
Rule of 40 score: 0
Market cap: 96012960 (Micro Cap ($50M-$300M))
Debt to equity: 0.0132
Free cash flow (dilution adjusted): -7374100.719424461
Operating income: -2046762.5899280577
Net income: -2005035.9712230216
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for EXT.AX (annual, report date 2026-03-31)
Altman Z-score: -15.881435151223641 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1462.5704894126236%
Free cash flow margin: -23.057139093952152%
Revenue growth: 90.02846264019419%
Rule of 40 score: 66.97132354624205
Market cap: 15740816 (Nano Cap (< $50M))
Debt to equity: -1.6612168499574913
Free cash flow (dilution adjusted): -3368061.6438356163
Operating income: -3407208.2191780824
Net income: -6003746.575342466
Long score: 3 | Short score: 13
Recommendation: Short
Stock screener scorecard for EXT.AX (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15740816 (Nano Cap (< $50M))
Debt to equity: -1.6612168499574913
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for GTG.AX (quarterly, report date 2024-09-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5671273 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HATHWAY.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 3.0569776111250184%
Rule of 40 score: 3.0569776111250184
Market cap: 19046324224 (Large Cap ($10B-$200B))
P/E ratio: 0.2800677186160887
Debt to equity: 0.0021
Operating income: 2109.927207511341
Net income: 2590990.6108239265
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HEALTHX.NS (annual, report date 2026-03-31)
Altman Z-score: 4.79431553603067 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.1628008901112805%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.328156863265171%
Free cash flow margin: -6.787837529569218%
Revenue growth: 8.80130317095186%
Rule of 40 score: 2.0134656413826413
Market cap: 9951915008 (Mid Cap ($2B-$10B))
P/E ratio: 7.13424995279928
Debt to equity: 0.0335
Free cash flow (dilution adjusted): -9406665.960152607
Operating income: -7453740.99194574
Net income: 124618.48240779992
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for HEALTHX.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.969741044492323 (Safe Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.5266020390527641%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.6704309846486773%
Revenue growth: 5.399891349914496%
Rule of 40 score: 5.399891349914496
Market cap: 9951915008 (Mid Cap ($2B-$10B))
P/E ratio: 7.13424995279928
Debt to equity: 0.0335
Operating income: -2390048.7494701142
Net income: -1183902.0771513353
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for HLS.TO (quarterly, report date 2026-03-31)
Altman Z-score: -1.0978051063562881 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.165941426685572%
Free cash flow margin: 45.41355721393035%
Revenue growth: -16.558693814938163%
Rule of 40 score: 28.85486339899219
Market cap: 128539976 (Micro Cap ($50M-$300M))
Debt to equity: 0.75
Free cash flow (dilution adjusted): 4202877.697841727
Operating income: -1593525.1798561153
Net income: -1652517.985611511
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for HVO.L (annual, report date 2025-12-31)
Altman Z-score: 2.4337895950958557 (Grey Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.162823236772553%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.983617166842329%
Free cash flow margin: -35.62097791460885%
Revenue growth: -19.385563323387153%
Rule of 40 score: -55.006541237996004
Market cap: 51630080 (Micro Cap ($50M-$300M))
Debt to equity: 0.3875
Free cash flow (dilution adjusted): -22514864.864864863
Operating income: -4372972.972972973
Net income: -8098648.6486486485
Long score: 3 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for HVO.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 51630080 (Micro Cap ($50M-$300M))
Debt to equity: 0.3875
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for LGCL (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 58194952 (Micro Cap ($50M-$300M))
P/E ratio: 3.6166666666666667
Debt to equity: 0.302
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for LGCL (annual, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 22787837.431362353
Rule of 40 score: 0
Market cap: 58194952 (Micro Cap ($50M-$300M))
P/E ratio: 3.6166666666666667
Debt to equity: 0.302
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NC1.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15731345 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NYE.MC (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13872791 (Nano Cap (< $50M))
Debt to equity: 0.7059000000000001
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NYE.MC (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.627040581517223%
Capitalized R&D asset: 0
Free cash flow margin: -141.31818465198964%
Revenue growth: 64.45300934280004%
Rule of 40 score: -76.8651753091896
Market cap: 13872791 (Nano Cap (< $50M))
P/E ratio: 75.31791677756452
Debt to equity: 0.7059000000000001
Free cash flow (dilution adjusted): -11112709.752941176
Operating income: 878801.8823529412
Net income: 722312.8588235294
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for PPGN.SW (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1444037120 (Small Cap ($300M-$2B))
Debt to equity: 0.415
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RAT.L (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 42.19753086419752%
Capitalized R&D asset: 0
Free cash flow margin: 111.5455431604029%
Revenue growth: 11.414461676767743%
Rule of 40 score: 122.96000483717064
Market cap: 1711981312 (Small Cap ($300M-$2B))
P/E ratio: 0.24041184041184038
Debt to equity: 0.0911
Free cash flow (dilution adjusted): 1391756756.7567568
Net income: 151756756.75675675
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for RAT.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1711981312 (Small Cap ($300M-$2B))
P/E ratio: 0.24041184041184038
Debt to equity: 0.0911
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RCR.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5467874 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RESI.L (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 52586372 (Micro Cap ($50M-$300M))
Debt to equity: 1.4369752372840108
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RKR.V (annual, report date 2025-12-31)
Altman Z-score: -24.947298000960476 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8122072 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -479933.57664233574
Operating income: -517262.0437956204
Net income: -480726.27737226273
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for RKR.V (quarterly, report date 2025-12-31)
Altman Z-score: -24.346782452441953 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8122072 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -173035.76642335765
Operating income: -214581.7518248175
Net income: -178045.98540145985
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for SHFS (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -24.536446878576523%
Capitalized R&D asset: 0
Free cash flow margin: -58.05152946195559%
Revenue growth: -67.93076659846123%
Rule of 40 score: -125.98229606041681
Market cap: 1253070 (Nano Cap (< $50M))
Debt to equity: 0.1026
Free cash flow (dilution adjusted): -1137565
Net income: -1779217
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for SQN.SW (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 30.73936298355863%
Capitalized R&D asset: 0
Free cash flow margin: 227.52520800811885%
Revenue growth: 24.195078127400503%
Rule of 40 score: 251.72028613551936
Market cap: 6100242944 (Mid Cap ($2B-$10B))
P/E ratio: 24.981692645674233
Debt to equity: 0.32530000000000003
Free cash flow (dilution adjusted): 2085814637.9746835
Net income: 463787897.4683544
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for SQN.SW (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6100242944 (Mid Cap ($2B-$10B))
P/E ratio: 24.981692645674233
Debt to equity: 0.32530000000000003
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TGEN (quarterly, report date 2026-03-31)
Altman Z-score: 2.1140768812884945 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.578335459189116%
Capitalized R&D asset: 668114
ROCI (R&D adjusted): -7.947081790235326%
Rosenberg metric: 2.0566022392380607
Free cash flow margin: -51.86276519866807%
Revenue growth: 19.138235854921344%
Rule of 40 score: -32.724529343746724
Market cap: 96335808 (Micro Cap ($50M-$300M))
Debt to equity: 0.1461
Free cash flow (dilution adjusted): -3285905
Operating income: -2133565
Net income: -2118655
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for THCH (quarterly, report date 2026-03-31)
Altman Z-score: -4.944520228593358 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -131.2056171706697%
Free cash flow margin: -9.170331189798278%
Revenue growth: -15.682892535278317%
Rule of 40 score: -24.853223725076596
Market cap: 52860272 (Micro Cap ($50M-$300M))
Debt to equity: -1.4680047396474831
Free cash flow (dilution adjusted): -3407235.8900144715
Operating income: -9518958.031837916
Net income: -15814037.626628075
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for TUF.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7466600 (Nano Cap (< $50M))
Debt to equity: 0.3115
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TUF.DE (annual, report date 2025-12-31)
Altman Z-score: -210.91386148344574 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -288.2165545832679%
Free cash flow margin: -10343.611682585155%
Rule of 40 score: -10343.611682585155
Market cap: 7466600 (Nano Cap (< $50M))
Debt to equity: 0.3115
Free cash flow (dilution adjusted): -1135087.2588235296
Operating income: -1000368.6352941176
Net income: -1042390.3882352941
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for UBS (quarterly, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.411402861260502%
Capitalized R&D asset: 0
Revenue growth: 11.475223378965497%
Rule of 40 score: 11.475223378965497
Market cap: 169593634816 (Large Cap ($10B-$200B))
P/E ratio: 54.414285714285725
Debt to equity: 3.717995286588398
Net income: 3817500000
Long score: 0 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 0900.HK (annual, report date 2026-02-28)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.44191570005695%
Capitalized R&D asset: 0
Free cash flow margin: 3.6580350624266456%
Revenue growth: 3.509321733377388%
Rule of 40 score: 7.167356795804034
Market cap: 3140741999.9999995 (Mid Cap ($2B-$10B))
P/E ratio: 6.7081347888397875
Debt to equity: 0.7742295860458674
Free cash flow (dilution adjusted): 8098721.227621483
Net income: 59871994.88491049
Long score: 4 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 3474.T (annual, report date 2025-12-31)
Altman Z-score: 2.8196689446127854 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.69880279605163%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.542268986586032%
Free cash flow margin: -4.123428307691927%
Revenue growth: 2.213109366801803%
Rule of 40 score: -1.9103189408901238
Market cap: 3953126651.945388 (Mid Cap ($2B-$10B))
Debt to equity: 0.6613803631089937
Free cash flow (dilution adjusted): -1704449.843360399
Operating income: -458730.26021354133
Net income: -1609104.2772201267
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for ALV.DE (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 26.090702947845802%
Capitalized R&D asset: 0
Free cash flow margin: 22.51291378683157%
Revenue growth: 10.926027037966906%
Rule of 40 score: 33.43894082479848
Market cap: 141595150316.4 (Large Cap ($10B-$200B))
P/E ratio: 12.38802714929134
Debt to equity: 0.5316583520475067
Free cash flow (dilution adjusted): 36404705882.35294
Net income: 13447058823.529411
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for ANOR.V (annual, report date 2025-03-31)
Altman Z-score: -18.429113386057733 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -41.34231073198877%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -50.72700282348453%
Rule of 40 score: 0
Market cap: 5449276.14 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -695457.3426573427
Operating income: -877951.7482517483
Net income: -716969.2307692308
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AYM.L (annual, report date 2025-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 59028.1227 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BIXI (annual, report date 2025-12-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 224284500 (Micro Cap ($50M-$300M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BOTJ (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.632187108450507%
Capitalized R&D asset: 0
Free cash flow margin: 21.976756360590514%
Revenue growth: 9.637945680372844%
Rule of 40 score: 31.61470204096336
Market cap: 83642852.58 (Micro Cap ($50M-$300M))
P/E ratio: 9.270987871868765
Debt to equity: 0.10988406955826505
Free cash flow (dilution adjusted): 10495000
Net income: 9022000
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for BY (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.334713027901808%
Capitalized R&D asset: 0
Free cash flow margin: 28.77440221785838%
Revenue growth: 9.40848490855925%
Rule of 40 score: 38.18288712641763
Market cap: 1313689862.87 (Small Cap ($300M-$2B))
P/E ratio: 10.10134380258514
Debt to equity: 0.3905652311764437
Free cash flow (dilution adjusted): 127041000
Net income: 130051000
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for CIVB (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.966734677548406%
Capitalized R&D asset: 0
Free cash flow margin: 24.297937239799552%
Revenue growth: 11.78759034717011%
Rule of 40 score: 36.08552758696966
Market cap: 455155321.2 (Small Cap ($300M-$2B))
P/E ratio: 9.849288522461698
Debt to equity: 0.5228934594847223
Free cash flow (dilution adjusted): 41263000
Net income: 46212000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for DCY.V (annual, report date 2025-07-31)
Altman Z-score: -23.039235860658398 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 254.46128562479151%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -80.34260005044219%
Rule of 40 score: 0
Market cap: 942696.7200000002 (Nano Cap (< $50M))
P/E ratio: 1.507031966390209
Debt to equity: 0
Free cash flow (dilution adjusted): -363439.13043478265
Operating income: -143118.115942029
Net income: 453284.0579710145
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for EPL.V (annual, report date 2025-12-31)
Altman Z-score: 7.03293881492963 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.847297135088201%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.712907214810705%
Free cash flow margin: -12.776639015839757%
Revenue growth: 22.482361656534604%
Rule of 40 score: 9.705722640694846
Market cap: 18432356.32 (Nano Cap (< $50M))
P/E ratio: 9.14820698212283
Debt to equity: 0
Free cash flow (dilution adjusted): -1105597.0802919706
Operating income: -553408.0291970803
Net income: 1470700.729927007
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ETL.V (annual, report date 2025-12-31)
Altman Z-score: 4.733715973369888 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.291082390319485%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -17.810221549082456%
Rule of 40 score: 0
Market cap: 81545249.52 (Micro Cap ($50M-$300M))
Debt to equity: 0.013513270355375619
Free cash flow (dilution adjusted): -16674452.554744525
Operating income: -7381751.824817518
Net income: -4523357.6642335765
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for GTG.AX (annual, report date 2024-06-30)
Altman Z-score: -41.419486871836675 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 1230860.0527974425
ROCI (R&D adjusted): -322.51122891723605%
Rosenberg metric: -0.3281012189242485
Free cash flow margin: -126.70957198532929%
Revenue growth: -11.169954633358653%
Rule of 40 score: -137.87952661868795
Market cap: 11633379.680000002 (Nano Cap (< $50M))
Debt to equity: 0.4781369252328023
Free cash flow (dilution adjusted): -6474676.666666667
Operating income: -8140141.333333333
Net income: -8011479.333333333
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for HLS.TO (annual, report date 2025-12-31)
Altman Z-score: -1.7348631790169573 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.6855522045095497%
Free cash flow margin: 24.351351351351347%
Revenue growth: 2.3166374084787105%
Rule of 40 score: 26.66798875983006
Market cap: 1563746.55 (Nano Cap (< $50M))
Debt to equity: 0.8078806550997242
Free cash flow (dilution adjusted): 9864963.503649633
Operating income: -2997080.2919708025
Net income: -9072992.700729927
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for KLIC (annual, report date 2025-09-30)
Altman Z-score: 8.53578232329593 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.1595725438757506%
Capitalized R&D asset: 229987458.87529704
ROCI (R&D adjusted): -2.957118582184703%
Rosenberg metric: 0.04637516131714547
Free cash flow margin: 10.371192558719791%
Revenue growth: -8.10235097656821%
Rule of 40 score: 2.2688415821515804
Market cap: 2717928900.1458 (Mid Cap ($2B-$10B))
P/E ratio: 12760.229578149294
Debt to equity: 0.046926868340614804
Free cash flow (dilution adjusted): 52586046.511627905
Operating income: -30537984.49612403
Net income: 165116.27906976745
Long score: 8 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for RESI.L (annual, report date 2025-09-30)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.80204709510649%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1036914.3736 (Nano Cap (< $50M))
Debt to equity: 1.4155722256572232
Free cash flow (dilution adjusted): 19221621.621621624
Net income: -12339189.18918919
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SHFS (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -24.67154805517497%
Capitalized R&D asset: 0
Free cash flow margin: -41.740161090078516%
Revenue growth: -32.40391261070184%
Rule of 40 score: -74.14407370078035
Market cap: 6843143.760000001 (Nano Cap (< $50M))
Debt to equity: 0.08627039058717023
Free cash flow (dilution adjusted): -4941189
Net income: -2160998
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for TGEN (annual, report date 2025-12-31)
Altman Z-score: 4.331491522666436 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -42.56039809101031%
Capitalized R&D asset: 2088378.42
ROCI (R&D adjusted): -23.32774049595595%
Rosenberg metric: -0.04747685938469824
Free cash flow margin: -39.37577819958919%
Revenue growth: 19.691712509045278%
Rule of 40 score: -19.684065690543914
Market cap: 147794682.88000003 (Micro Cap ($50M-$300M))
Debt to equity: 0.13112885381620085
Free cash flow (dilution adjusted): -10660484
Operating income: -7131518
Net income: -8248755
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for THCH (annual, report date 2025-12-31)
Altman Z-score: -3.826240622074527 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -143.65977191733242%
Free cash flow margin: -6.169312530767349%
Revenue growth: -1.3336313492987546%
Rule of 40 score: -7.502943880066104
Market cap: 558396700.47 (Small Cap ($300M-$2B))
Debt to equity: -1.5924001308597784
Free cash flow (dilution adjusted): -11600039.142857144
Operating income: -35794813.85714286
Net income: -62069785
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for UBS (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.016633639584459%
Capitalized R&D asset: 0
Free cash flow margin: 41.20731578390951%
Revenue growth: 18.820578985655718%
Rule of 40 score: 60.02789476956522
Market cap: 116914393492.134 (Large Cap ($10B-$200B))
P/E ratio: 14.99479203438938
Debt to equity: 3.713827859069006
Free cash flow (dilution adjusted): 24669620253.164555
Net income: 9869620253.164557
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0881.HK (annual, report date 2025-12-31)
Altman Z-score: 2.4682199733481367 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.483802952804244%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.01080321024811%
Free cash flow margin: 3.932995241437423%
Revenue growth: 1.9777546011295586%
Rule of 40 score: 5.9107498425669815
Market cap: 10012384256 (Large Cap ($10B-$200B))
Debt to equity: 0.7962
Free cash flow (dilution adjusted): 923711285.7142857
Operating income: -185457428.57142857
Net income: -239041142.85714287
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 0881.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10012384256 (Large Cap ($10B-$200B))
Debt to equity: 0.7962
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1123.HK (annual, report date 2026-03-31)
Altman Z-score: 2.1748143449850703 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.930230468640683%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.030479332044363%
Free cash flow margin: 2.0793695164068207%
Revenue growth: -1.0287756288908172%
Rule of 40 score: 1.0505938875160035
Market cap: 133940976 (Micro Cap ($50M-$300M))
P/E ratio: 1.403061224489796
Debt to equity: 0.0872
Free cash flow (dilution adjusted): 2647193.8775510206
Operating income: 2856887.7551020407
Net income: 966326.530612245
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 1123.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 133940976 (Micro Cap ($50M-$300M))
P/E ratio: 1.403061224489796
Debt to equity: 0.0872
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1170.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 289908704 (Micro Cap ($50M-$300M))
Debt to equity: 0.0085
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1170.HK (annual, report date 2026-03-31)
Altman Z-score: 1.9214229702233898 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.746373424520489%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.335953422823259%
Free cash flow margin: -9.489574068583853%
Revenue growth: -3.735960412579596%
Rule of 40 score: -13.225534481163448
Market cap: 289908704 (Micro Cap ($50M-$300M))
Debt to equity: 0.0085
Free cash flow (dilution adjusted): -7348852.040816327
Operating income: -11497959.18367347
Net income: -9008035.714285715
Long score: 3 | Short score: 8
Recommendation: Short
Stock screener scorecard for 1608.HK (annual, report date 2025-12-31)
Altman Z-score: -0.49115775231651315 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -17.395447009963934%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.76414499170606%
Free cash flow margin: -34.18059905891392%
Revenue growth: -21.106507867656322%
Rule of 40 score: -55.287106926570246
Market cap: 453524896 (Small Cap ($300M-$2B))
Debt to equity: 1.2642
Free cash flow (dilution adjusted): -52837275.06426735
Operating income: -17534575.83547558
Net income: -25860539.845758352
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 1608.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 453524896 (Small Cap ($300M-$2B))
Debt to equity: 1.2642
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2219.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1803046784 (Small Cap ($300M-$2B))
P/E ratio: 1.0796915167095116
Debt to equity: 0.0987
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2281.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 541617280 (Small Cap ($300M-$2B))
P/E ratio: 0.5912596401028277
Debt to equity: 0.6713
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2281.HK (annual, report date 2025-12-31)
Altman Z-score: 0.681737411420486 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.754697627397237%
Capitalized R&D asset: 2378.466877637131
ROCI (R&D adjusted): 5.4121502088534825%
Free cash flow margin: 23.19419712365078%
Revenue growth: -3.0434112621695038%
Rule of 40 score: 20.15078586148128
Market cap: 541617280 (Small Cap ($300M-$2B))
P/E ratio: 0.5912596401028277
Debt to equity: 0.6713
Free cash flow (dilution adjusted): 40980060.74714286
Operating income: 41996510.04571428
Net income: 16608801.841428572
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 274A.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 16387707904 (Large Cap ($10B-$200B))
P/E ratio: 0.17786005900716978
Debt to equity: 1.0259
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3271.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 35976830976 (Large Cap ($10B-$200B))
P/E ratio: 0.0562866275090214
Debt to equity: 3.5325
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3550.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3005928192 (Mid Cap ($2B-$10B))
P/E ratio: 0.1268355427396179
Debt to equity: 0.3569
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3601.HK (annual, report date 2025-12-31)
Altman Z-score: 5.056561477396178 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.464066061419811%
Capitalized R&D asset: 11480960.036166366
ROCI (R&D adjusted): 3.6763259311674656%
Rosenberg metric: -0.6447230537678705
Free cash flow margin: 2.4369303620302136%
Revenue growth: -13.453965506827847%
Rule of 40 score: -11.017035144797633
Market cap: 204440000 (Micro Cap ($50M-$300M))
P/E ratio: 1.0282776349614395
Debt to equity: 0.0026
Free cash flow (dilution adjusted): 3799428.5714285714
Operating income: 4620857.142857143
Net income: 3729142.8571428573
Long score: 7 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 3601.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 204440000 (Micro Cap ($50M-$300M))
P/E ratio: 1.0282776349614395
Debt to equity: 0.0026
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 4019.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5339069440 (Mid Cap ($2B-$10B))
P/E ratio: 0.15953054627087776
Debt to equity: 0.08349999999999999
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 4880.T (quarterly, report date 2026-04-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6232020992 (Mid Cap ($2B-$10B))
P/E ratio: 0.6454006847929882
Debt to equity: 0.00421542205031841
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5986.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5377025024 (Mid Cap ($2B-$10B))
P/E ratio: 0.03024618946406656
Debt to equity: 0.3265
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5986.T (annual, report date 2026-03-31)
Altman Z-score: 2.2763823842412805 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.369146678598876%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.2952777420325416%
Free cash flow margin: 1.9461637130899045%
Revenue growth: -10.668100869335568%
Rule of 40 score: -8.721937156245664
Market cap: 5377025024 (Mid Cap ($2B-$10B))
P/E ratio: 0.03024618946406656
Debt to equity: 0.3265
Free cash flow (dilution adjusted): 5867811.561561561
Operating income: 2781963.2132132133
Net income: 6531462.712712713
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 7122.T (annual, report date 2026-03-31)
Altman Z-score: 1.4784831422516247 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.479262025778552%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.5836721458681501%
Free cash flow margin: 37.19407008086254%
Revenue growth: 14.776300906783108%
Rule of 40 score: 51.970370987645644
Market cap: 16223230976 (Large Cap ($10B-$200B))
P/E ratio: 0.05745065986029841
Debt to equity: 0.039
Free cash flow (dilution adjusted): 86330080.08008008
Operating income: -1463963.963963964
Net income: 9822322.322322322
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 7122.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 16223230976 (Large Cap ($10B-$200B))
P/E ratio: 0.05745065986029841
Debt to equity: 0.039
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7261.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 708579557376 (Mega Cap (>= $200B))
P/E ratio: 0.11693200666037507
Debt to equity: 0.4517
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7388.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 49307332608 (Large Cap ($10B-$200B))
P/E ratio: 0.18058053586301662
Debt to equity: 0.09300000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7810.T (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2608178688 (Mid Cap ($2B-$10B))
P/E ratio: 0.6291697333744867
Debt to equity: 1.8841999999999999
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8020.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 352541212672 (Mega Cap (>= $200B))
P/E ratio: 0.07087253157929617
Debt to equity: 0.8190999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8230.T (annual, report date 2026-03-31)
Altman Z-score: 2.200593537906083 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.871794871794871%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.54171562867215%
Free cash flow margin: -0.3219392103020547%
Revenue growth: -6.861307086245846%
Rule of 40 score: -7.1832462965479005
Market cap: 5729972224 (Mid Cap ($2B-$10B))
P/E ratio: 0.1272326599837517
Debt to equity: 0.36479999999999996
Free cash flow (dilution adjusted): -425425.4254254254
Operating income: 4836086.086086086
Net income: 1820570.5705705704
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 8230.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5729972224 (Mid Cap ($2B-$10B))
P/E ratio: 0.1272326599837517
Debt to equity: 0.36479999999999996
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8308.HK (annual, report date 2025-12-31)
Altman Z-score: -0.4870672500213028 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -23.420223899829654%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.946196905896194%
Free cash flow margin: 9.87958607714017%
Revenue growth: 3.836375314456993%
Rule of 40 score: 13.715961391597162
Market cap: 62496036 (Micro Cap ($50M-$300M))
Debt to equity: 1.5437
Free cash flow (dilution adjusted): 750142.8571428572
Operating income: -3525571.4285714286
Net income: -8847428.57142857
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 8308.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 62496036 (Micro Cap ($50M-$300M))
Debt to equity: 1.5437
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8496.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10913176 (Nano Cap (< $50M))
Debt to equity: -0.14147493068843844
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 8529.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 107388384 (Micro Cap ($50M-$300M))
P/E ratio: 1.0282776349614395
Debt to equity: 1.0278
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 8529.HK (annual, report date 2025-12-31)
Altman Z-score: 1.6290144139618064 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.574303071049538%
Capitalized R&D asset: 1168682.6256148184
ROCI (R&D adjusted): 15.197656994409536%
Rosenberg metric: 4.994278766202316
Free cash flow margin: 2.089257820322826%
Revenue growth: 22.171449852673945%
Rule of 40 score: 24.26070767299677
Market cap: 107388384 (Micro Cap ($50M-$300M))
P/E ratio: 1.0282776349614395
Debt to equity: 1.0278
Free cash flow (dilution adjusted): 536375.3213367609
Operating income: 1894473.0077120822
Net income: 1645886.889460154
Long score: 8 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AIBG.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 19657175040 (Large Cap ($10B-$200B))
P/E ratio: 0.1288851351351351
Debt to equity: 0.7521611871213667
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AIBG.L (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 17.28764126868392%
Capitalized R&D asset: 0
Free cash flow margin: 183.4072759538598%
Revenue growth: 3.5887738615283236%
Rule of 40 score: 186.99604981538812
Market cap: 19657175040 (Large Cap ($10B-$200B))
P/E ratio: 0.1288851351351351
Debt to equity: 0.7521611871213667
Free cash flow (dilution adjusted): 9727058823.529411
Net income: 2518823529.4117646
Long score: 4 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for ALDNX.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 39488432 (Nano Cap (< $50M))
P/E ratio: 7.710651828298886
Debt to equity: 0.0088
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ALDNX.PA (annual, report date 2025-12-31)
Altman Z-score: 3.827010377292222 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1355.1809228379352%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 33.987489605144916%
Free cash flow margin: 7.446906164020486%
Revenue growth: 18.547143969637617%
Rule of 40 score: 25.994050133658103
Market cap: 39488432 (Nano Cap (< $50M))
P/E ratio: 7.710651828298886
Debt to equity: 0.0088
Free cash flow (dilution adjusted): 2118823.529411765
Operating income: 7413440
Net income: 6441970.588235294
Long score: 12 | Short score: 0
Recommendation: Long
Stock screener scorecard for ALHAF.PA (quarterly, report date 2025-09-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 41026348 (Nano Cap (< $50M))
Debt to equity: 0.20489999999999997
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ATEC (quarterly, report date 2026-03-31)
Altman Z-score: -1.133416571513613 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 38652340
ROCI (R&D adjusted): -4.014586897346855%
Rosenberg metric: -0.5841299762129168
Free cash flow margin: -19.094467695254753%
Revenue growth: -9.777953110910731%
Rule of 40 score: -28.872420806165486
Market cap: 1270299776 (Small Cap ($300M-$2B))
Debt to equity: 33.0335
Free cash flow (dilution adjusted): -36682000
Operating income: -22056000
Net income: -33906000
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BDMD (annual, report date 2025-12-31)
Altman Z-score: 3.0538879663622875 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -82.79131831089992%
Capitalized R&D asset: 3640959.953351169
ROCI (R&D adjusted): -24.66121037537248%
Rosenberg metric: -2.0991152843826275
Free cash flow margin: -83.67313578692051%
Revenue growth: -36.542323676336416%
Rule of 40 score: -120.21545946325693
Market cap: 32621386 (Nano Cap (< $50M))
Debt to equity: 0.621
Free cash flow (dilution adjusted): -2693918.2857142854
Operating income: -3648201.5714285714
Net income: -3896857.8571428573
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for BDMD (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 32621386 (Nano Cap (< $50M))
Debt to equity: 0.621
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BRCK.L (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 170040368 (Micro Cap ($50M-$300M))
Debt to equity: 0.6426999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BST.DE (quarterly, report date 2026-03-31)
Altman Z-score: 2.042491798287505 (Grey Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.082126763945588%
Revenue growth: -26.717870930258858%
Rule of 40 score: -26.717870930258858
Market cap: 85151296 (Micro Cap ($50M-$300M))
P/E ratio: 15.421455938697319
Debt to equity: 0.07490000000000001
Operating income: -1694252.8735632184
Net income: -337931.0344827586
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CNTY (quarterly, report date 2026-03-31)
Altman Z-score: -0.08476365820241033 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.126061875487022%
Free cash flow margin: -2.9911322583230713%
Revenue growth: -0.5449630773021429%
Rule of 40 score: -3.5360953356252143
Market cap: 32916238 (Nano Cap (< $50M))
Debt to equity: -44.27806363973161
Free cash flow (dilution adjusted): -4105000
Operating income: 11763000
Net income: -14784000
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CXH (annual, report date 2025-11-30)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.16134714752328974%
Capitalized R&D asset: 0
Free cash flow margin: 1576.6568252773523%
Revenue growth: -81.33861755477025%
Rule of 40 score: 1495.318207722582
Market cap: 31280024 (Nano Cap (< $50M))
P/E ratio: 380
Debt to equity: 0.6215999999999999
Free cash flow (dilution adjusted): 2974505
Net income: 114042
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CXH (quarterly, report date 2025-11-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 31280024 (Nano Cap (< $50M))
P/E ratio: 380
Debt to equity: 0.6215999999999999
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for DCBO.TO (quarterly, report date 2026-03-31)
Altman Z-score: 0.4973329754617642 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 19870386.703775667
ROCI (R&D adjusted): 1.8330672981476188%
Rosenberg metric: 0.019181484664494264
Free cash flow margin: 35.6796708320634%
Revenue growth: 2.599786376460663%
Rule of 40 score: 38.279457208524065
Market cap: 694723200 (Small Cap ($300M-$2B))
P/E ratio: 10.630041421408327
Debt to equity: -136.03571428570916
Free cash flow (dilution adjusted): 16843884.892086335
Operating income: -28057.553956834534
Net income: -1164748.201438849
Long score: 4 | Short score: 11
Recommendation: Short